EVALUATION OF SAFETY OF STANDARD CHEMOTHERAPY IN COMBINATION WITH DASATINIB IN ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL)
- Registry ID
- EUCTR2010-022854-18
- Source registry
- EUCTR
- Status
- Prematurely Ended
- Phase
- PHASE2
- Sponsor
- Dekan des Fachbereichs Medizin der Goethe Universität, represented by the Coordinating Investigator
- Start date
- 2011-02-23
- Completion date
- 2015-09-30
- Last update
- 2026-08-16
Conditions
- Philadelphia chromosome positive Acute Lymphoblastic Leukemia
Summary
To evaluate the feasibility of a combination of Dasatinib and standard chemotherapy in adult ALL
Locations
View on source registry